Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer × Standard of Care × 90 days × Clear all

Sponsor

Conditions

Neoplasms 12 Colorectal Neoplasms 12 Breast Neoplasms 10 Prostatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 6 Hematologic Neoplasms 6 Hematopoietic and Lymphatic System Neoplasm 5 Urinary Bladder Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Breast Carcinoma In Situ 4 Sarcoma 3 Motor Activity 3 Leukemia, Myeloid, Acute 3 Stomach Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Follicular 2 Lymphedema 2 Hemangiosarcoma 2 Head and Neck Neoplasms 2 Frailty 2 Fallopian Tube Neoplasms 2 Carcinoma, Squamous Cell 2

Interventions

olaparib 2 Pluvicto 2 testosterone 17 beta-cypionate 1 sarilumab 1 radium Ra 223 dichloride 1 lactitol 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 enfortumab vedotin 1 darolutamide 1 cemiplimab 1 Radium-223 1 Prednisone 1 Prednisolone 1 PSMA-617 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Cyclophosphamide 1 Blood Specimen Collection 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡